- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02042716
Added Value of Supersonic Shear Imaging in the Diagnosis of White Matter Damage in Preterm Infants (BELUGA)
Preterm birth and perinatal events related can interrupt microscopic maturation of the developing white matter leading to diffuse injury and subsequent neurocognitive impairments. Brain maturation can be studied using diffusion tensor imaging but is difficult to assess early after birth, repeatedly and at the bedside. Supersonic Shear wave Imaging (SSI) could be of interest in this clinical setting. This technique, already investigated in adults (breast, thyroid or liver fibrosis staging), has not been yet evaluated in neonates.
Objective:
To describe the feasibility and reproducibility of quantitative elasticity mapping in preterm infants and to correlate to gestational age.
Methods:
SSI is a quantitative stiffness imaging technique based on the combination of a remote palpation induced into tissues by the radiation force a focused ultrasonic beam and an ultrafast ultrasound imaging sequence. Such ultrafast frame rates permit to track in real time the displacements induced by the propagation of the resulting shear waves. For each pixel, the shear wave speed can be estimated locally and enables quantitative mapping of the local shear elasticity (characterizing the stiffness in kPa). In this study, we will use a new generation of ultrafast ultrasound scanners (Aixplorer®, Supersonic Imagine, Aix en Provence, France) with a linear L10-2 probe (256 elements, 6 MHz) in neonates born between 25 and 40 weeks' gestation (n=100). Three separate acquisitions will be obtained for each area of interest both on right and left sides and stiffness was measured using a unique ROI of 2.5 cm².
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75019
- Hopital Robert Debre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- gestational age between 24 +0 and 31 +6 j GA) and 39 +0 and 40 +6 d (control group)
- Inborn or Outborn
- Informed consent of the holders of the exercise of parental authority
- recipient of a social security system (excluding AME) Child
Exclusion Criteria:
- Malformation known pathology;
- Known chromosomal abnormality;
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: diagnosis of white matter damage
Added value of supersonic shear imaging in the diagnosis of white matter damage in preterm infants
|
Added value of supersonic shear imaging in the diagnosis of white matter damage in preterm infants
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sequences quantitative elastography and ultra-sensitive Doppler ultrasound performed on AixplorerTM (V2) data of brain MRI preterm infants.
Time Frame: Up to on 40GA + /-1week fo preterm infants<32GA. For newborns at term:on day3+-1d
|
To describe the feasibility and reproducibility of quantitative elasticity mapping in preterm infants and to correlate to gestational age
|
Up to on 40GA + /-1week fo preterm infants<32GA. For newborns at term:on day3+-1d
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation and comparison of measures elastography MRI to determine the prognosis of brain abnormalities detected by elastography
Time Frame: For preterm infants <32GA:up to 40GA+/-1 week.For newborns at term :on day3+-1
|
Longitudinal comparison of measures of quantitative elastography in the supratentorial white matter, corpus callosum, gray matter (basal ganglia) and white matter infratentorial (cerebellar hemispheres) during development in preterm infants <32 weeks and compared the values obtained in the newborn term. For preterm infants <32GA:on day0-day1, day3 + /-1d, day8, day21 + /-1d; 40GA + /-1week.For newborns at term :on day3+-1 |
For preterm infants <32GA:up to 40GA+/-1 week.For newborns at term :on day3+-1
|
Quantitative cerebral perfusion values obtained by Doppler ultra-sensitive
Time Frame: up to 40GA + /-1week for preterm infants <32GA .For newborns at term :on day3+-1
|
Quantitative cerebral perfusion values obtained by Doppler ultra-sensitive (with standard setting speeds) in premature infants with and without white matter lesions in the frontal white matter and basal ganglia (temporal curve of blood flow in the region interest with defined and standardized measurement of peak systolic and diastolic values: pulsatility index.
|
up to 40GA + /-1week for preterm infants <32GA .For newborns at term :on day3+-1
|
Cerebral perfusion values obtained by Doppler ultra-sensitive
Time Frame: on day21 + /-1d
|
Cerebral perfusion values obtained by ultra-sensitive Doppler in premature infants with abnormal EEG characterized (positive rolandic spikes> 2 min, convulsions ...) during the first 21 days of life.
|
on day21 + /-1d
|
Collaborators and Investigators
Investigators
- Principal Investigator: Biran Valerie, MP,PHD, Assistance Publique - Hôpitaux de Paris
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P120601
- ID RCB : 2012-A01530-43 (OTHER: ID RCB)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm
-
Istanbul University - Cerrahpasa (IUC)CompletedPreterm Labor | Preterm Spontaneous Labor With Preterm Delivery | Preterm Labor With Preterm Delivery in Third TrimesterTurkey
-
Ain Shams UniversityRecruitingPreterm Labor With Preterm DeliveryEgypt
-
University Hospital, Strasbourg, FranceRecruitingPreterm Delivery | Threatened Preterm LaborFrance
-
PreTeL, IncDuke University; University of RochesterRecruitingPreterm Birth | Threatened Preterm Labor | PreTerm LaborUnited States
-
Konya Meram State HospitalRecruitingPregnancy Preterm | Preterm Labor Without DeliveryTurkey
-
University of Modena and Reggio EmiliaNot yet recruitingPreterm Labor With Preterm DeliveryItaly
-
e-Bio CorpRecruitingPreterm Labor | PreTerm Birth | Preterm Labor With Delivery NosUnited States
-
Chelsea and Westminster NHS Foundation TrustSPD Development Company Limited; Borne CharityRecruitingPreterm Birth | Preterm Labor | Preterm Birth Complication | Preterm Premature Rupture of Membrane | Preterm PregnancyUnited Kingdom
-
Ethem Unal, M.D., PhD, Associate Prof of Surgery...UnknownPreterm Birth | Preterm Labor | Preterm Labor Without Delivery | Side Effect of Drug | Preterm Labor With Preterm Delivery in Third Trimester | Calcium-Channel Blockers Toxicity
-
Federico II UniversityRecruiting
Clinical Trials on diagnosis of white matter damage in preterm infants
-
CEU San Pablo UniversityCompleted
-
Ospedale di Circolo - Fondazione MacchiCompletedInfant Conditions | Infant Behavior | Infant MorbidityItaly
-
Ospedale di Circolo - Fondazione MacchiCompleted